BPC-157 vs PEG-MGF (Pegylated Mechano Growth Factor)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

✅ Stacking Partners — These compounds are commonly used together and may have synergistic effects.
BPC-157PEG-MGF (Pegylated Mechano Growth Factor)
CategoryPeptidesGrowth Factors
Standard DoseResearch indicates 250-500 mcg administered 1-2 times daily via subcutaneous injection near the site of injury.Research indicates 200-500 mcg administered 2-3 times per week via subcutaneous or intramuscular injection.
TimingAdminister on an empty stomach or near the injury site. No strict meal timing required, though fasted state may improve absorption for oral dosing.On non-training days or several hours post-workout (to avoid competing with natural MGF pulse). Unlike native MGF, timing is more flexible due to extended half-life.
Cycle DurationTypical cycles range from 4-12 weeks depending on the injury being addressed.4-8 week cycles.
Evidence Levelanimal_plus_anecdotalanimal_plus_anecdotal
A

BPC-157

Peptides

Mechanism

BPC-157 is a 15-amino acid peptide derived from human gastric juice that promotes angiogenesis via dual VEGFR2-dependent (PI3K-Akt-eNOS) and VEGF-independent (Src-Caveolin-1-eNOS) nitric oxide pathways. It upregulates growth hormone receptor expression, modulates the FAK-paxillin pathway for cell migration, and counteracts damage to the nitric oxide system. Additionally, it enhances tendon fibroblast growth, promotes reticulin and collagen formation, and accelerates wound healing by mediating the NO system's protective functions.

Standard Dosing

Research indicates 250-500 mcg administered 1-2 times daily via subcutaneous injection near the site of injury.

Timing

Administer on an empty stomach or near the injury site. No strict meal timing required, though fasted state may improve absorption for oral dosing.

Cycle Duration

Typical cycles range from 4-12 weeks depending on the injury being addressed.

Side Effects

  • Mild nausea (rare)
  • Dizziness (rare)
  • Injection site irritation
  • Headache (uncommon)

Contraindications

  • Active cancer or history of cancer (theoretical concern with angiogenesis promotion)
  • Pregnancy and breastfeeding
  • Children under 18

Best Stacking Partners

TB-500GHK-CuPentadeca Arginate (PDA)

Mechanism

PEG-MGF is the pegylated form of Mechano Growth Factor, where polyethylene glycol (PEG) molecules are covalently attached to protect against rapid enzymatic breakdown. This extends the half-life from 5-7 minutes (native MGF) to approximately 48-72 hours. Like native MGF, it activates satellite cell proliferation, promotes muscle fiber regeneration and hypertrophy, and supports tissue repair. The extended half-life allows for systemic distribution rather than purely local action, enabling subcutaneous rather than intramuscular administration.

Standard Dosing

Research indicates 200-500 mcg administered 2-3 times per week via subcutaneous or intramuscular injection.

Timing

On non-training days or several hours post-workout (to avoid competing with natural MGF pulse). Unlike native MGF, timing is more flexible due to extended half-life.

Cycle Duration

4-8 week cycles.

Side Effects

  • Injection site soreness
  • Mild hypoglycemia
  • Water retention
  • Localized swelling

Contraindications

  • Active cancer
  • Pregnancy and breastfeeding
  • Under 25 years of age

Best Stacking Partners

HGHIGF-1 LR3BPC-157

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →